Sign in

NCT07129369Not yet recruiting

Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program

Evaluating the Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program for Adults With Recent-onset Psychosis: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 19 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Psychosis is a very disabling mental illness with a wide range of dysregulations and disruptions in cognition, emotions, and behaviors, resulting in poor functioning and frequent relapses, especially in the first five years of the illness. There is a knowledge gap about whether Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) can have longer-term and more significant benefits than current professional-led psychoeducation in diverse health outcomes of these psychotic patients such as functioning, problem-solving, and recovery. This multi-center randomized controlled trial with repeated measures, 3-arm design is proposed to test and compare the effects between two alternative interventions (PASIM and Psychoeducation Group program) and a usual-care-only group over an 18-month follow-up.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
186 (estimated)
First submitted
6 Aug 2025
Start date
2 Jan 2026
Primary completion date
31 Aug 2028
Lead sponsor
Chinese University of Hong Kong
NCT number
NCT07129369

What you commit to

  • Study type: Interventional
  • Planned participants: 186
  • From 2 Jan 2026 to the primary completion date, 31 Aug 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have received or are receiving other psychotherapies;

Other illness

  • Comorbidity with other mental (learning disability, cognitive, or personality disorder) or significant medical disease(s);

Other

  • And/or communication, visual or hearing difficulty.

Who the study is looking for

  • Primarily diagnosed with psychosis (or ROP with \<5 years of illness as defined in recent literature), including brief, first-episode and other psychotic disorders according to the criteria of the DSM-5 \[American Psychiatric Association 2013\];
  • H.K. Chinese residents, aged 18-64 years;
  • Global Assessment of Functioning scores ≥51, indicating mild to moderate symptoms and difficulties in psychosocial/occupational functioning \[American Psychiatric Association 2013\], being mentally stable to comprehend APSI or psychoeducation and outcome measures;
  • Able to read and understand Cantonese/ Mandarin.

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Psychiatric outpatient clinics in one hospital cluster of Hospital Authority
Coordinator of this site? Confirm its status
Hong KongChinaUnknown status
Integrated Community Centers for Mental Wellness
Coordinator of this site? Confirm its status
Hong KongChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.